EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology

Diana A Gorog, Jurriën M Ten Berg, Gianluca Campo, Tobias Geisler, Bruna Gigante, Erik L Grove, Sigrun Halvorsen, Kurt Huber, Young-Hoon Jeong, Gregory Y H Lip, Eliano P Navarese, Andrea Rubboli und 7 weitere

EuroIntervention · 2026-06 · 22 (12) · e653-e677

DOI: 10.4244/eij-e-26-00003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EuroIntervention, 2026-06. Verfasst von Diana A Gorog und 18 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London SW3 6LY, United Kingdom. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Acute Coronary Syndrome, Fibrinolytic Agents, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionAcute Coronary SyndromeFibrinolytic AgentsPlatelet Aggregation InhibitorsSecondary PreventionHumansHemorrhageRisk FactorsDual Anti-Platelet TherapyThrombosis

Substanzen

Fibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Faculty of Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London SW3 6LY, United Kingdom.
  • Centre for Health Services Research, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire AL10 9AB, United Kingdom.
  • St Antonius Hospital, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Cardiology Department, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Cardiology Division, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
  • Department of Cardiology and Angiology, University Hospital, Tübingen, Germany.

Zitieren

APA

Gorog, D. A., Ten Berg, J. M., Campo, G., Geisler, T., Gigante, B., Grove, E. L., Halvorsen, S., Huber, K., Jeong, Y. H., Lip, G. Y. H., Navarese, E. P., Rubboli, A., Siller Matula, J. M., Storey, R. F., Valgimigli, M., Vandenbriele, C., Vilahur, G., Ahrens, I., & Ferreiro, J. L. (2026). Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the E…. EuroIntervention, 22(12), e653-e677. https://doi.org/10.4244/eij-e-26-00003

Vancouver

Gorog DA, Ten Berg JM, Campo G, Geisler T, Gigante B, Grove EL, et al. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the E…. EuroIntervention. 2026;22(12):e653-e677. doi:10.4244/eij-e-26-00003

BibTeX
@article{Gorog2026,
  author = {Gorog, Diana A and Ten Berg, Jurriën M and Campo, Gianluca and Geisler, Tobias and Gigante, Bruna and Grove, Erik L and Halvorsen, Sigrun and Huber, Kurt and Jeong, Young-Hoon and Lip, Gregory Y H and Navarese, Eliano P and Rubboli, Andrea and Siller Matula, Jolanta M and Storey, Robert F and Valgimigli, Marco and Vandenbriele, Christophe and Vilahur, Gemma and Ahrens, Ingo and Ferreiro, Jose Luis},
  title = {Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the E…},
  journal = {EuroIntervention},
  year = {2026},
  volume = {22},
  number = {12},
  pages = {e653--e677},
  doi = {10.4244/eij-e-26-00003}
}
Kostenlos starten →